
Adipamidoxime
CAS No. 15347-78-1
Adipamidoxime( —— )
Catalog No. M18072 CAS No. 15347-78-1
Adipamidoxime is an active compound.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 45 | In Stock |
![]() ![]() |
5MG | 65 | In Stock |
![]() ![]() |
10MG | 104 | In Stock |
![]() ![]() |
25MG | 185 | In Stock |
![]() ![]() |
50MG | 277 | In Stock |
![]() ![]() |
100MG | 417 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameAdipamidoxime
-
NoteResearch use only, not for human use.
-
Brief DescriptionAdipamidoxime is an active compound.
-
DescriptionAdipamidoxime is an active compound.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number15347-78-1
-
Formula Weight174.2
-
Molecular FormulaC6H14N4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN=C(NO)CCCCC(=N)NO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
MK-886
MK-886 is an inhibitor of leukotriene biosynthesis, inhibiting 5-lipoxygenase-activating protein (FLAP). It is also a moderately potent PPARα antagonist.
-
meplazumab
meplazumab is a humanized anti-CD147 antibody, as add-on therapy in patients with COVID-19 pneumonia.
-
SB290157 trifluoroac...
SB290157 trifluoroacetate is a potent and selective antagonist of C3a receptor(IC50 of 200 nM). SB 290157 is a competitive antagonist of 125I-C3a radioligand binding to rat basophilic leukemia-2H3 cells expressing the human C3aR (RBL-C3aR, IC50 of 200 nM).